Cargando…
Difference in Biomarkers Between COVID-19 Patients and Other Pulmonary Infection Patients
BACKGROUND: The pandemic due to the novel coronavirus disease 2019 (COVID-19) has resulted in an increasing number of patients need to be tested. We aimed to determine if the use of integrated laboratory data can discriminate COVID-19 patients from other pulmonary infection patients. METHODS: This r...
Autores principales: | Dai, Jingyi, Du, Yingrong, Gao, Jianpeng, Zhao, Jun, Wang, Lin, Huang, Ying, Xia, Jiawei, Luo, Yu, Li, Shenghao, McNeil, Edward B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397211/ https://www.ncbi.nlm.nih.gov/pubmed/32801798 http://dx.doi.org/10.2147/IDR.S257936 |
Ejemplares similares
-
Biomarkers and sociodemographic factors predicting one-year readmission among liver cirrhosis patients
por: Dai, Jingyi, et al.
Publicado: (2019) -
Adherence to Hepatocellular Carcinoma Surveillance and Perceived Barriers Among High-Risk Chronic Liver Disease Patients in Yunnan, China
por: Dai, Jingyi, et al.
Publicado: (2020) -
Endothelial glycocalyx degradation is more severe in patients with non-pulmonary sepsis compared to pulmonary sepsis and associates with risk of ARDS and other organ dysfunction
por: Murphy, Laura S., et al.
Publicado: (2017) -
Angiopoietin-2 outperforms other endothelial biomarkers associated with severe acute kidney injury in patients with severe sepsis and respiratory failure
por: Yu, Wen-Kuang, et al.
Publicado: (2021) -
CD8(+) T cells predicted the conversion of common covid-19 to severe
por: Liu, Li, et al.
Publicado: (2021)